DEXA Scans for Semaglutide: Tracking Fat, Muscle, and Bone Changes

Dr. Sajad Zalzala

Medically Reviewed

Dr. Sajad Zalzala, MD

Board-certified Family Medicine Physician

Written by Amelia Willson

Published: April 27, 2026 11 Min Read
A woman receiving a DEXA scan in a clinical setting to assess body composition during weight loss treatment.

Photo Credit: izusek / iStock

Key Takeaways

  • DEXA scans can help semaglutide users monitor changes in body composition, including fat mass, lean mass, visceral fat, and bone-related metrics.
  • Scale weight and BMI do not show whether weight loss is coming from fat, muscle, or other lean tissue.
  • Some lean mass loss can happen during weight reduction, so tracking muscle changes may help guide adjustments to protein intake and strength training.
  • Visceral fat is linked to cardiometabolic risk, and DEXA scans can help measure changes that a standard scale cannot capture.
  • A baseline scan and follow-up scans may help patients and clinicians better evaluate whether weight loss is supporting long-term health, not just a lower number on the scale.

GLP-1 medications like semaglutide can produce up to 15% weight loss in under a year and a half.

With results like these, the conversation is no longer about how to lose weight. It’s about how to do so in a healthy way. You don’t just want to be a lighter version of yourself. You want to be a healthier one, too.

That’s where DEXA scans come in. Short for dual-energy x-ray absorptiometry, this scan is a valuable tool for anyone losing weight on semaglutide. DEXA scans help guide your weight-loss journey, ensuring that the pounds you lose come from fat, not muscle.

For why that difference matters, and how DEXA scans for semaglutide users work, read on.


Weight loss is easy to measure, but health is not. If you’re only watching the scale, you’re flying blind. The real goal isn’t just to lose weight — it’s to improve body composition, and that requires better data.

Dr. Sajad Zalzala, Board-certified Family Medicine Physician and Medical Advisor at SkinnyRx


Limitations of BMI and Scale Weight in Assessing Health

For decades, patients and healthcare providers have relied heavily on the bathroom scale and the body mass index (BMI) to gauge health and weight loss success. However, these old-school tools are fundamentally flawed because they don’t capture the full picture:

  • A bathroom scale simply tells you how much you weigh, not how much of that weight represents fat (which you want to lose) or muscle (which you don’t want to lose). Worse, it can be a source of frustration. As you start building muscle, that number on the scale might not change — leading you to feel defeated instead of motivated.
  • BMI can also be misleading. It creates an assessment solely based on your weight and height, with no accounting for your muscle vs. body fat composition. As a result, an ultra-muscular Olympic athlete could be labeled “overweight” or even “obese” when they’re actually quite healthy.

These tools can be inaccurate (in the case of BMI) and demotivating (in the case of the bathroom scale) for some people. But, they can also mask real issues that can happen when you’re losing weight quickly, as so many people do with semaglutide.

Explore Personalized Weight Loss Options

Explore Personalized Weight Loss Options

Start with an online assessment to help a licensed clinician determine whether a prescription weight loss treatment may be appropriate for you.

Risk of Muscle Loss During Semaglutide Treatment

Losing weight brings a lot of health benefits, from lower blood pressure and cholesterol to being able to walk or play with your kids without feeling exhausted. There’s only one potential downside: the loss of muscle mass.

There are a number of reasons you don’t want to lose muscle mass (beyond looking great in a gym selfie):

  • Muscle provides critical strength and stability to your bones and joints. Having a healthy amount of muscle is one of the best ways to prevent injury and stay mobile well into your golden years.
  • Low muscle mass is a risk factor for other serious health issues. These can include a higher risk of death, heart problems, and type 2 diabetes.
  • Muscle is metabolically active and constantly burning calories, even while you are deep asleep. When you lose muscle, you slow down your metabolism, which not only slows your weight loss now but also increases your risk of weight gain in the future.

Expected Lean Mass Loss During Weight Reduction

Before you get too worried, know that almost all weight loss tends to include some loss of lean body mass. This is not a unique phenomenon to semaglutide — or other GLP-1s, for that matter.

In typical diet-induced weight loss, the loss of lean tissue (which includes muscle, bone, and water) represents about 20% to 30% of the total mass lost.

However, because GLP-1s like semaglutide can help you lose weight so quickly, the risk of muscle loss is also higher. In fact, research shows as much as 15% to 40% of weight lost comes from muscle instead of fat.

This amount of lean tissue loss can lead to a serious condition called sarcopenic obesity (essentially, being “skinny fat”). You may reach a “normal” BMI or a low body weight, but your body composition has way too much fat and way too little muscle. This leaves you looking lean on the outside but lacking the functional strength to support your joints, mobility, and a healthy metabolism.

To understand the dangers of being “skinny fat” on semaglutide, think of your weight loss as an iceberg melting in the ocean. The portion of the iceberg visible above the water represents your scale weight. It is easy to see, simple to measure, and highly satisfying to watch shrink.

However, the massive, hidden structure underwater represents your lean muscle mass and bone density. This underwater foundation is what keeps you stable, upright, and metabolically resilient. If that underwater foundation melts away too rapidly, the entire structure becomes unstable, causing you to “capsize” into a state of metabolic slowdown and physical frailty.

Note: There are active steps people can take to avoid becoming skinny fat on semaglutide. When coupled with a protein-rich diet and regular strength training, the muscle loss can be kept to a minimum.

For many people, their body-fat-to-muscle ratio usually improves, as the drug helps them lose body fat without too much muscle. Still, it’s a real risk, and something DEXA scans can help you watch out for.

How a DEXA Scan Works: The Gold Standard of Body Data

If weight loss is a melting iceberg, a DEXA scan is the medical-grade sonar that allows you to see the whole iceberg clearly. Originally developed to evaluate bone density, dual-energy x-ray absorptiometry (DEXA) is considered the gold-standard technology for body composition analysis.

The process is surprisingly quick and painless. You’ll lie down fully clothed on a table while a scanning arm passes over your body, emitting two low-dose X-ray beams at different energy levels.

Because different tissues in your body absorb X-rays at different rates, the machine can precisely differentiate between your bone, fat mass, and lean muscle. Don’t worry, the amount of radiation is tiny — equivalent to roughly half a day of natural background radiation.

Infographic explaining why DEXA scans matter on semaglutide, showing scale weight limits, possible lean mass loss, body composition tracking, and results that may guide next steps.

Fat Mass vs. Lean Mass vs. Bone Mineral Content

A DEXA scan report provides a comprehensive breakdown of your body composition, showing you your:

  • Total body fat percentage
  • Total fat mass
  • Total lean mass
  • Visceral fat
  • Bone mineral content

Not only that, the report breaks down these percentages by body area, such as your arms, legs or torso. This segmental analysis allows you to see exactly where you are losing fat and whether your exercise routine is successfully building muscle in specific regions.

Visceral Fat and Its Role in Metabolic Risk

Not all fat acts the same way in the body. While subcutaneous fat sits just under the skin, visceral fat is the deeper “deadly” fat that wraps around internal organs like the liver, secreting dangerous hormones along the way. It’s more commonly known as belly fat.

Excessive visceral fat is a major risk factor for various cardiometabolic diseases, including heart disease, fatty liver disease, type 2 diabetes, and even cancer — so it’s worth losing it. Unlike your bathroom scale, DEXA scans can actually see this fat and help you track how much you lose while taking semaglutide.

Using DEXA Results to Adjust Your Approach

A DEXA scan can be an invaluable tool in understanding your body composition on Ozempic® or Wegovy®. You can use your muscle mass and visceral fat DEXA results to make targeted changes to your weight loss approach, from boosting your protein intake to strength-based workouts.

When to Increase Protein Intake

If your body composition analysis indicates excessive lean tissue loss, step one is aggressively increasing your protein intake. That’s because protein is the basic building block of muscle. Plus, it offers other benefits for semaglutide users, such as a nice metabolism boost and increased satiety.

So, how much protein should you eat on semaglutide? Experts recommend a healthy intake of 0.55 to 0.73 grams of protein per pound of body weight to support muscle preservation on GLP-1 medications, although some research suggests you can go as high as 1 gram per pound.

Good sources of protein include:

  • Lean chicken
  • Fish and seafood
  • Low-fat yogurt and cheese
  • Protein shakes or bars
  • Beans and lentils
  • Nuts and seeds

Role of Strength Training in Preserving Muscle Mass

Now that you’re eating more of the foods that help you build muscle, it’s time to go out there and actually build it! Resistance training and targeted strength workouts are non-negotiable for people taking semaglutide.

These are exercises that use free weights, resistance bands, or even your own body weight as a form of resistance. For example:

  • Weightlifting
  • Yoga
  • Pilates
  • Squats and lunges
  • Push-ups

DEXA scans show that nine months of resistance training can lead to significant increases in your resting metabolic rate. Translation: doing more of these workouts helps your body burn more calories when you’re not working out.

For people taking GLP-1s, experts recommend at least 3 strength-training workouts per week. If your DEXA scans show a loss of lean muscle, you’ll want to bump that number up.

Explore Personalized Weight Loss Options

Explore Personalized Weight Loss Options

Start with an online assessment to help a licensed clinician determine whether a prescription weight loss treatment may be appropriate for you.

Monitoring Bone Density During Weight Loss

While much of this conversation has centered around fat and muscle, your bones are just as important. That’s why an increasing amount of research has focused on actively monitoring the effects of GLP-1s on bone density. As we mentioned above, rapid weight loss can lead to bone loss, too.

Fortunately, a few studies have shown that taking GLP-1s did not significantly increase the risk of bone fracture, although researchers note that more studies are needed.

This is yet another area where regular DEXA scans can help. Experts recommend getting an initial baseline scan, ideally before starting semaglutide. From there, follow-up scans may take place every three to six months while you’re actively losing weight.

Once you’ve reached your goal weight, a yearly maintenance scan can make sure things are still heading in the right direction.

Frequently Asked Questions

To effectively monitor your progress, it’s best to get a baseline DEXA scan before, or close to, beginning treatment with semaglutide. In weight-loss studies, follow-up DEXA scans were performed every 3 to 6 months, sometimes longer. Your healthcare provider can recommend the right cadence for you, based on your rate of weight loss.


No, there is a massive accuracy gap between at-home “smart scales” and DEXA scans. technology gap in 2026 regarding at-home body composition tracking. Researchers warn against using smart scales to measure your body composition.


Some muscle loss is inevitable during weight loss, so the goal is to minimize it. Experts recommend keeping lean mass reduction to less than 20% of your total weight lost. To prevent muscle mass loss, increase your protein intake and your strength-training sessions.


DEXA scans are rarely covered by insurance. Out-of-pocket, DEXA scans cost around $50 to $150.


First, do not panic. Then, take actions to change it. Increase your daily protein intake to at least 0.73 grams per pound of your body weight. Crank up your resistance training workouts, either by adding more weight or resistance or adding more sessions per week. Finally, talk to your doctor. They may want to lower your semaglutide dosage to slow down the loss of lean body mass and rebalance your body composition.


  1. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. PMID: 33567185: https://www.nejm.org/doi/10.1056/NEJMoa2032183
  2. Willoughby D, Hewlings S, Kalman D. Body Composition Changes in Weight Loss: Strategies and Supplementation for Maintaining Lean Body Mass, a Brief Review. Nutrients. 2018 Dec 3;10(12):1876. doi: 10.3390/nu10121876. PMID: 30513859; PMCID: PMC6315740: https://www.mdpi.com/2072-6643/10/12/1876
  3. Cava E, Yeat NC, Mittendorfer B. Preserving Healthy Muscle during Weight Loss. Adv Nutr. 2017 May 15;8(3):511-519. doi: 10.3945/an.116.014506. PMID: 28507015; PMCID: PMC5421125: https://www.sciencedirect.com/science/article/pii/S2161831322006810?via%3Dihub
  4. McCarthy D, Berg A. Weight Loss Strategies and the Risk of Skeletal Muscle Mass Loss. Nutrients. 2021 Jul 20;13(7):2473. doi: 10.3390/nu13072473. PMID: 34371981; PMCID: PMC8308821: https://pmc.ncbi.nlm.nih.gov/articles/PMC8308821/
  5. Memel Z, Gold SL, Pearlman M, Muratore A, Martindale R. Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. Curr Nutr Rep. 2025 Apr 28;14(1):63. doi: 10.1007/s13668-025-00649-w. PMID: 40289060: https://pubmed.ncbi.nlm.nih.gov/40289060/
  6. Uchiyama S, Sada Y, Mihara S, Sasaki Y, Sone M, Tanaka Y. Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes. J Clin Med Res. 2023 Jul;15(7):377-383. doi: 10.14740/jocmr4987. Epub 2023 Jul 31. PMID: 37575352; PMCID: PMC10416191: https://pmc.ncbi.nlm.nih.gov/articles/PMC10416191/
  7. Wilding JPH, Batterham RL, Calanna S, Van Gaal LF, McGowan BM, Rosenstock J, et al. Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study. J Endocr Soc. 2021 May 3;5(Suppl 1):A16–7. doi: 10.1210/jendso/bvab048.030: https://pmc.ncbi.nlm.nih.gov/articles/PMC8089287/
  8. Slart RHJA, Punda M, Ali DS, Bazzocchi A, Bock O, Camacho P, et al. Updated practice guideline for dual-energy X-ray absorptiometry (DXA). Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):539-563. doi: 10.1007/s00259-024-06912-6: https://pmc.ncbi.nlm.nih.gov/articles/PMC11732917/
  9. Lee MJ, Kim J. The pathophysiology of visceral adipose tissues in cardiometabolic diseases. Biochem Pharmacol. 2024 Apr;222:116116. doi: 10.1016/j.bcp.2024.116116. Epub 2024 Mar 8: https://pmc.ncbi.nlm.nih.gov/articles/PMC11407912/
  10. Kokura Y, Ueshima J, Saino Y, Maeda K. Enhanced protein intake on maintaining muscle mass, strength, and physical function in adults with overweight/obesity: A systematic review and meta-analysis. Clin Nutr ESPEN. 2024 Oct;63:417-426. doi: 10.1016/j.clnesp.2024.06.030. Epub 2024 Jun 24: https://pubmed.ncbi.nlm.nih.gov/39002131/
  11. Moon J, Koh G. Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss. J Obes Metab Syndr. 2020 Sep 30;29(3):166-173. doi: 10.7570/jomes20028: https://pmc.ncbi.nlm.nih.gov/articles/PMC7539343/
  12. Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025 Aug;33(8):1475-1503. doi: 10.1002/oby.24336. PMID: 40445127; PMCID: PMC12304835: https://onlinelibrary.wiley.com/doi/10.1002/oby.24336
  13. Almandoz JP, Wadden TA, Tewksbury C, et al. Nutritional considerations with antiobesity medications. Obesity (Silver Spring). 2024;32(9):1613-1631. doi:10.1002/oby.24067: https://onlinelibrary.wiley.com/doi/10.1002/oby.24067
  14. Aristizabal JC, Freidenreich DJ, Volk BM, Kupchak BR, Saenz C, Maresh CM, Kraemer WJ, Volek JS. Effect of resistance training on resting metabolic rate and its estimation by a dual-energy X-ray absorptiometry metabolic map. Eur J Clin Nutr. 2015 Jul;69(7):831-6. doi: 10.1038/ejcn.2014.216. Epub 2014 Oct 8. PMID: 25293431: https://pubmed.ncbi.nlm.nih.gov/25293431/
  15. Hansen MS, Wölfel EM, Jeromdesella S, Møller JK, Ejersted C, Jørgensen NR, et al. Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. EClinicalMedicine. 2024 May 3;72:102624. doi: 10.1016/j.eclinm.2024.102624. PMID: 38737002; PMCID: PMC11087719: https://www.sciencedirect.com/science/article/pii/S2589537024002037
  16. Tan Y, Liu S, Tang Q. Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis. Acta Diabetol. 2025 May;62(5):589-606. doi: 10.1007/s00592-025-02468-5. Epub 2025 Feb 22. PMID: 39985672: https://pubmed.ncbi.nlm.nih.gov/39985672/
  17. Frija-Masson J, Mullaert J, Vidal-Petiot E, Pons-Kerjean N, Flamant M, d'Ortho MP. Accuracy of Smart Scales on Weight and Body Composition: Observational Study. JMIR Mhealth Uhealth. 2021 Apr 30;9(4):e22487. doi: 10.2196/22487. PMID: 33929337; PMCID: PMC8122302: https://pmc.ncbi.nlm.nih.gov/articles/PMC8122302/
Amelia Willson

By Amelia Willson

Contributing Author

Amelia Willson is a freelance health writer and content strategist based in Orange County, California. Her work has appeared in several health publications, including Ro, Klarity Health, K Health, Sleep Foundation, and A Place For Mom. Amelia covers the latest trends in health and wellness, including the research (or lack thereof) behind them, breaking down complex topics so that readers don't have to. Her writing frequently explores weight management, plant-based nutrition, and mental health.